Recent Updates
Recently added Catalysts
PRPO Positive Sentiment Score: 70/100

Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call Conference Call to be held on Monday, April 3 rd , 2023 at 5:00 PM EST NEW HAVEN, CT, Globenewswire - (March 28 th , 2023) - Specialty cancer di

Key Takeaway: Precipio, Inc. is set to host its Q4 2022 and year-end shareholder update call on April 3, 2023. This call will provide important updates regarding the company's core businesses and future plans. Participants can pre-register for the call and submit questions in advance. The company emphasizes its commitment to improving diagnostic accuracy through collaborations with leading academic institutions, which is fundamental to enhancing patient care.

Market Sentiment Analysis

POSITIVE FACTORS

  • Precipio is hosting a shareholder update call to discuss current core businesses.
  • The company has developed a platform for accurate cancer diagnostics.
  • Collaboration with world-class academic institutions enhances diagnostic precision.

Full Press Release Details

2022 Fourth Quarter and Year-End
Shareholder Update Call
Call to be held on Monday, April 3rd, 2023 at 5:00 PM EST
NEW HAVEN, CT, Globenewswire
- (March 28th, 2023) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO),
will be hosting its Q4-2022 and year end shareholder update call on Monday, April 3rd at 5:00 PM ET. The call will include
updates on the Company's current core businesses.
conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio
Inc. conference call. Participants may also pre-register for the conference call at https://dpregister.com/sreg/10177120/f8d2d6fc60.
For those that pre-register for the shareholder call, the host service will send a calendar invitation and a direct dial-in number for
the call to your email used during registration, which will allow for the registrant to bypass the operator.
Listeners interested
in submitting questions in advance should email their questions to investors@precipiodx.com and management will do its best
to address those questions during the call.
A replay of the call
will be available approximately 24 hours after the call and may be accessed via the investors page located on Precipio's website or at
Precipio has built a platform designed to eradicate
the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering
quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide.
Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio
offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit www.precipiodx.com.
@PrecipioDx and on Facebook.
Forward-Looking Statements
This press release contains "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19)
pandemic, and the related responses of the government, consumers, and the company, on our business, financial condition and results of
operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions
and uncertainties. Except for historical information, statements about future volumes, sales, growth, costs, cost savings, margins, earnings,
earnings per share, diluted earnings per share, cash flows, plans, objectives, expectations, growth or profitability are forward-looking
statements based on management's estimates, beliefs, assumptions and projections. Words such as "could," "may,"
"expects," "anticipates," "will," "targets," "goals," "projects,"
"intends," "plans," "believes," "seeks," "estimates," "predicts,"
and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic
and financial performance, are intended to identify such forward-looking statements. These forward-looking statements are only predictions,
subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect
performance and cause results to differ materially from management's expectations, or could affect the company's ability
to achieve its strategic goals, include the uncertainties relating to the impact of COVID-19 on the company's business, operations
and employees and the other factors that are described in the sections entitled "Risk Factors" and "Management's
Discussion and Analysis" in the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as updated from
time to time in the company's Securities and Exchange Commission filings.
The company's forward-looking statements
in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events and
speak only as of the date of this release. The company undertakes no obligation to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

Frequently Asked Questions

When is the Precipio shareholder update call scheduled?

The Precipio shareholder update call is set for April 3rd, 2023 at 5:00 PM ET.

How can investors join the Precipio conference call?

Investors can join by calling 844-695-5519 or 1-412-902-6760 for international callers.

Where can I send questions for the Precipio call?

Questions can be emailed to investors@precipiodx.com prior to the call.

Will there be a replay of the shareholder call?

Yes, a recording will be available approximately 24 hours after the call.

What does Precipio specialize in?

Precipio specializes in cancer diagnostics and aims to reduce misdiagnosis.

Last updated: Mar 29, 2023